Modification of 6,7-Dichloro-5,8-Quinolinedione at C2 Position: Synthesis, Quantum Chemical Properties, and Activity against DT-Diaphorase Enzyme
Source abstract
Abstract
This research presents a synthesis and characterization of new 6,7-dichloro-5,8-quinolinedione derivatives with various groups at the C2 position. Chemical structures were examined by the spectroscopic methods. The quantum chemical parameters calculated using the DFT method showed that these derivatives are highly reactive towards the nucleophilic target. The molecular electrostatic potential map (MEP) showed that nucleophilic regions are localized near the nitrogen atom and the formyl group. Introduction of the hydroxyl or formyl groups at the C2 position led to the formation of an additional nucleophilic region. New compounds were tested as substrates for the NQO1 protein. An enzymatic study showed that derivatives are a good substrate for the NQO1 enzyme. Moreover, it was shown that the enzymatic conversion rates depend on the type of substituent at the C2 position of the 5,8-quinolinedione scaffold. A molecular docking study was used to study the interaction between new derivatives and the NQO1 protein. The arrangement and type of interactions between derivatives and the NQO1 enzyme depended on the type of substituent at the C2 position. A derivative with the hydroxyl group at this position was found to form an additional hydrogen bond between the formyl group and the tyrosine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bioactive Compounds and Antitumor Agents · Free Radicals and Antioxidants · Organic Chemistry Cycloaddition Reactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland
Funding
Medical University of Silesia in Katowice, Poland
References (52)
Show source-provided references
1. Diaphorase activities in liver ctoplasmic fractions
2. The diverse functionality of NQO1 and its roles in redox control10.1016/j.redox.2021.101950 ↗
3. NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms10.1016/j.bbapap.2019.05.002 ↗
4. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues10.1016/S0891-5849(00)00310-5 ↗
5. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors
6. Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue10.1124/mol.61.2.320 ↗
7. The activity of the DT-diaphorase in experimental hepatomas
8. Structure-based development of anticancer drugs: Complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones10.1016/S0969-2126(01)00636-0 ↗
9. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: Mechanism of the two-electron reduction10.1073/pnas.92.19.8846 ↗
10. One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase)10.1016/0005-2728(70)90220-3 ↗
11. DT-diaphorase. Redox potential, steady-state, and rapid reaction studies10.1074/jbc.270.3.1198 ↗
12. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues10.1007/BF00689804 ↗
13. Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents10.1016/j.ejmech.2020.112396 ↗
14. Dicoumarol: A drug which hits at least two very different targets in vitamin K metabolism10.2174/1389450116666150722141906 ↗
15. Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism
16. Treatment of pancreatic cancer cells with dicumarol induces cytotoxicity and oxidative stress10.1158/1078-0432.CCR-03-0667 ↗
17. NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones10.1016/j.bcp.2011.12.017 ↗
18. Genotoxicity of streptonigrin: A review10.1016/S1383-5742(00)00062-4 ↗
19. The total synthesis of streptonigrin and related antitumor antibiotic natural products10.1016/j.tet.2004.02.060 ↗
20. Total synthesis of the antitumor antibiotic (±)-streptonigrin: First- and second-generation routes for de novo pyridine formation using ring-closing metathesis10.1021/jo402388f ↗
21. Kadela-Tomanek, M., Bębenek, E., Chrobak, E., and Boryczka, S. (2019). 5,8-Quinolinedione scaffold as a promising moiety of bioactive agents. Molecules, 24.10.3390/molecules24224115 ↗
22. Kadela-Tomanek, M., Jastrzębska, M., Chrobak, E., Bębenek, E., and Latocha, M. (2022). Hybrids of 1,4-quinone with quinoline derivatives: Synthesis, biological activity, and molecular docking with DT-Diaphorase (NQO1). Molecules, 27.10.3390/molecules27196206 ↗
23. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate10.1016/j.bioorg.2020.104478 ↗
24. The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones10.1016/j.bmc.2010.03.021 ↗
25. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities10.1016/j.ejmech.2018.05.025 ↗
26. Synthesis of antifungal evaluation of 2H-[1,2,3]Triazolo [4,5-g]isoquinoline-4,9-diones10.1248/cpb.c14-00527 ↗
27. Synthesis and SAR of aziridinylquinoline-5,8-diones as agents against malignant tumor cells
28. Structural, vibrational and quantum chemical investigations for 6,7-dichloro-2-methyl-5,8-quinolinedione. Cytotoxic and molecular docking studies10.1016/j.molstruc.2018.05.031 ↗
29. Study on relationship between fluorescence properties and structure of substituted 8-hydroxyquinoline zinc complexes10.1007/s10895-018-2275-7 ↗
30. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., and Petersson, G.A. (2016). Gaussian 16, Gaussian Inc.. Revision A. 03. 2016.
31. Efficient implementation of the gauge-independent atomic orbital method for NMR chemical shift calculations10.1021/ja00179a005 ↗
32. Foresman, J., and Frisch, E. (1996). Exploring Chemistry with Electronic Structure Methods: A Guide to Using Gaussian, Gaussian.
33. Molecular electrostatic potentials: An effective tool for the elucidation of biochemical phenomena10.1289/ehp.8561191 ↗
34. Dennington, R., Keith, T., and Millam, J. (2009). GaussView, Version 5, Semichem Inc.
35. (2023, January 10). pkCSM. Available online: http://biosig.unimelb.edu.au/pkcsm/prediction#.
36. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures10.1021/acs.jmedchem.5b00104 ↗
37. Novel naphtho [2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation10.1016/j.bmc.2016.01.024 ↗
38. 2-Substituted 3-methylnaphtho [1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)10.1016/j.ejmech.2014.05.041 ↗
39. The crystal structure of NAD(P)H Quinone Oxidoreductase 1 in complex with its potent inhibitor dicoumarol10.1021/bi0600087 ↗
40. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading10.1002/jcc.21334 ↗
41. (2022, December 12). Dessault Systemes BIOVIA. Available online: https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/.
42. Self—Consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules10.1063/1.1677527 ↗
43. A comparison of models for calculating nuclear magnetic resonance shielding tensors10.1063/1.471789 ↗
44. Quantitative characterization of the global electrophilicity pattern of some reagents involved in 1,3-dipolar cycloaddition reactions10.1016/S0040-4020(03)00374-0 ↗
45. Domingo, L.R., Ríos-Gutiérrez, M., and Pérez, P. (2016). Applications of the conceptual density functional theory indices to organic chemistry reactivity. Molecules, 21.10.3390/molecules21060748 ↗
46. Ali, B., Khalid, M., Asim, S., Khan, M.U., Iqbal, Z., Hussain, A., Hussain, R., Ahmed, S., Ali, A., and Hussain, A. (2021). Key electronic, linear and nonlinear optical properties of designed disubstituted quinoline with carbazole compounds. Molecules, 26.10.3390/molecules26092760 ↗
47. Synthesis, crystal structure and DFT study of a novel compound N-(4-(2,4-dimorpholinopyrido [2,3-d]pyrimidin-6-yl)phenyl)pyrrolidine-1-carboxamide10.1016/j.molstruc.2021.130261 ↗
48. DFT, molecular docking and SERS (concentration and solvent dependant) investigations of a methylisoxazole derivative with potential antimicrobial activity10.1016/j.molstruc.2021.130034 ↗
49. Structural, spectral, thermodynamical, NLO, HOMO, LUMO and NBO analysis of fluconazole10.1016/j.saa.2015.06.018 ↗
50. Relevance of molecular docking studies in drug designing10.2174/1574893615666191219094216 ↗
51. 2D- and 3D-QSAR modeling of imidazole-based glutaminyl cyclase inhibitors
52. ESOL: Estimating aqueous solubility directly from molecular structure